|
|
|
|
|
|
by jlebrech
3316 days ago
|
|
|
Martin Shkreli explained that most of his revenue came from insurance companies and health services and not the patient directly. He raised the price of a drug that had better alternatives but those alternatives were too pricey, bringing it's price up, brought them down too. |
|
|